Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/08/2010US7731958 Adjust concentration of interleukins
06/08/2010US7731957 variant peptide; one-hundred-fold or more increase in cocaine hydrolysis compared to wild-type butyrylcholinesterase
06/08/2010US7731956 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system
06/08/2010US7731955 Using lactoperoxidase composition as a therapeutic treatment for rheumatoid arthritis, sepsis, myleoma and influenza infection
06/08/2010US7731954 Wound dressings comprising hydrated hydrogels and enzymes
06/08/2010US7731953 inducing proliferation of CD4+ T cells using human thymic stromal derived lymphopoietin (TSLP) polypeptide; asthma or rhino-conjunctivitis
06/08/2010US7731951 Viruses for the treatment of cellular proliferative disorders
06/08/2010US7731949 4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
06/08/2010US7731948 Stabilized interferon liquid formulations
06/08/2010US7731947 Composition and dosage form comprising an interferon particle formulation and suspending vehicle
06/08/2010US7731946 Methods and compositions for modulating T helper (TH) cell development and function
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010US7731653 System and method for genetically treating cardiac conduction disturbances
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2423960C Separation of cresol from mares' urine
06/08/2010CA2397670C .beta.-turn peptidomimetic cyclic compounds
06/08/2010CA2383233C Surface modified particulate compositions of biologically active substances
06/08/2010CA2379210C Composition for enteral nutrition containing fibre
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/08/2010CA2289916C A novel strain of bacillus for controlling plant diseases and corn rootworm
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/03/2010WO2010062995A2 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
06/03/2010WO2010062955A1 Treating neoplasms with neurotoxin
06/03/2010WO2010062863A2 Compositions containing satiogens and methods of use
06/03/2010WO2010062768A1 Method for the treatment of hemophilia
06/03/2010WO2010062762A2 Compositions and methods for reducing the signs of aging of the skin
06/03/2010WO2010062756A2 Preventing and treating sepsis
06/03/2010WO2010062587A1 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds, and uses thereof
06/03/2010WO2010062573A1 Synthetic mimetics of host defense and uses thereof
06/03/2010WO2010062570A2 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
06/03/2010WO2010062413A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
06/03/2010WO2010062401A2 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010WO2010062264A1 Lipopeptide compounds and their use
06/03/2010WO2010062217A1 Agent for eliminating multidrug resistance
06/03/2010WO2010062159A1 Bioactive compounds
06/03/2010WO2010062057A2 Composition for promoting implantation of embryo or pregnancy
06/03/2010WO2010061915A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
06/03/2010WO2010061880A1 Vesicle preparation
06/03/2010WO2010061787A1 Beauveriolide having acat-2 inhibitory activity
06/03/2010WO2010061269A2 Improving cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf)
06/03/2010WO2010061246A1 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment
06/03/2010WO2010061204A1 Cecropin-magainin hybrid peptides
06/03/2010WO2010061203A1 Biocidal fusion peptide comprising ll-37
06/03/2010WO2010060990A1 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment
06/03/2010WO2010060901A1 Peptides for treatment of obesity
06/03/2010WO2010060667A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
06/03/2010WO2010060636A1 Antimicrobial therapy
06/03/2010WO2010060497A1 A nonapeptide with anti-tumour activity
06/03/2010WO2010060479A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
06/03/2010WO2010060266A1 Neuregulin and cardiac stem cells
06/03/2010WO2010060265A1 Neuregulin peptides and their use
06/03/2010WO2010060155A1 Compositions and methods for treatment of celiac disease
06/03/2010WO2010040803A3 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
06/03/2010WO2010039801A3 Methods of treating hepatitis c virus infection
06/03/2010WO2010037514A3 Novel immunotherapy against several tumors including neuronal and brain tumors
06/03/2010WO2010033854A3 Avian derived fusion proteins
06/03/2010WO2010022262A3 Methods for treating type i diabetes with leptin and leptin agonists
06/03/2010WO2010019276A3 Method and formulation for treating adverse biological conditions
06/03/2010WO2010019266A3 Linaclotide-containing formulations for oral administration
06/03/2010WO2010007166A3 Treatment of inflammatory bowel diseases with mammal beta defensins
06/03/2010WO2010007165A3 Treatment of inflammatory diseases with mammal beta defensins
06/03/2010WO2008131348A3 Compositions and methods for treatment of uncontrolled cell growth
06/03/2010US20100138957 Hybrid peptides having antimicrobial activity and methods of making and using hybrid peptides
06/03/2010US20100138948 Transgenic plants with controlled distribution of a trait to progeny
06/03/2010US20100137976 Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors
06/03/2010US20100137816 Injection of fibrin sealant including an anesthetic in spinal applications
06/03/2010US20100137696 Medical device with reservoir-based sensors
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137227 Methods and compositions for treating conditions
06/03/2010US20100137226 Fatigue-reducing agent
06/03/2010US20100137225 drug delivery to liver tissue of a complex or conjugate of drug and polypeptide comprising the amino acid sequence of SEQ ID NO:61; biodrug is siRNA molecule
06/03/2010US20100137224 Method of reducing injury to mammalian cells
06/03/2010US20100137223 Neuropeptide-2 receptor (y-2r) agonists and uses thereof
06/03/2010US20100137222 Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents
06/03/2010US20100137221 Peptides that interact with topoisomerase i and methods thereof
06/03/2010US20100137220 Blood sugar-modulating polypeptides
06/03/2010US20100137219 Methods and Compositions for Inhibiting Binding IgE to a High Affinity Receptor
06/03/2010US20100137218 Expression System of NELL Peptide
06/03/2010US20100137217 Fibrosis inhibitor for implanted organ
06/03/2010US20100137216 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use
06/03/2010US20100137215 Novel tetrahydro-1h-pyrido[4,3-b]indoles
06/03/2010US20100137214 Chimeric hirudin proteins
06/03/2010US20100137213 Formulations of single domain antigen binding molecules
06/03/2010US20100137212 Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
06/03/2010US20100137211 Methods and compositions for intra-articular coagulation proteins
06/03/2010US20100137210 Gastrointestinal proliferative foctor and uses thereof
06/03/2010US20100137209 Modified plasminogen activator inhibitor type-1 and methods based thereon
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137207 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting g protein coupled receptors using the same
06/03/2010US20100137206 Novel ligand guided block copolymers for targeted drug delivery
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137204 Glp-1 pharmaceutical compositions
06/03/2010US20100137203 Method for preparing a cell-derived extracellular matrix membrane
06/03/2010US20100137202 Compositions for reprogramming a cell and uses therefor
06/03/2010US20100137201 Medicaments
06/03/2010US20100137200 Methods for treatment of growth disorders
06/03/2010US20100137199 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137197 Lyophilized anti-fungal composition
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 3163